loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 203441 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 TEDUGLUTIDE RECOMBINANT (1)

filter

01 TAKEDA PHARMS USA (1)

filter

01 POWDER;SUBCUTANEOUS (1)

filter

01 5MG/VIAL (1)

filter

01 USA (1)

URL Supplier Web Content
POWDER;SUBCUTANEOUS
5MG/VIAL
GATTEX KIT
USA
203441
2012-12-21
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 203441

Looking for CTD TGA MCC DOSSIER APPLICATION 203441 1

19

Takeda Pharmaceutical, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is TEDUGLUTIDE RECOMBINANT, with a corresponding application number 203441 and regulatory information .

proudly manufactured in the

approval since 2012-12-21

Takeda Pharmaceutical's GATTEX KIT POWDER;SUBCUTANEOUS, medication with 5MG/VIAL of TEDUGLUTIDE RECOMBINANT.

Post Enquiry
POST ENQUIRY